On September 3, 2026 Quince Therapeutics, Inc. (Nasdaq: QNCX), a clinical stage biopharmaceutical company focused on the development of novel, disease modifying therapies for serious underserved diseases, reported that senior management will participate in the following investor conferences in September 2026:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cantor Global Healthcare Conference: Fireside chat on Wednesday, September 9, 2026 at 2:45 p.m. ET
H.C. Wainwright 28th Annual Global Investment Conference: Company presentation available on Monday, September 14, 2026

A webcast of each event will be accessible by visiting the "Events" section on the "Investors" page of Quince’s website at www.quincetx.com. A replay of the webcasts will be available following the presentation and will be archived for at least 30 days.

(Press release, Quince Therapeutics, SEP 3, 2026, View Source [SID1234670574])

On September 3, 2026 Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) reported that it is scheduled to participate in the following upcoming investor events:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2026 Cantor Global Healthcare Conference – September 9-11, 2026

Type: Fireside Chat Presentation
Date/Time: September 10, 2026, 10:55 am EDT

Morgan Stanley 24th Annual Global Healthcare Conference – September 14-16, 2026

Type: Fireside Chat Presentation
Date/Time: September 15, 2026, 11:30 am EDT

H.C. Wainwright 28th Annual Global Investment Conference – September 14-16, 2026

Type: Fireside Chat Presentation
Date/Time: September 16, 2026, 9:00 am EDT

Presentation materials and webcast links, if applicable, may be accessed on the Events and Presentations page under the Investors section of the Arrowhead website.

(Press release, Arrowhead Pharmaceuticals, SEP 3, 2026, View Source [SID1234670573])

On September 3, 2026 ADC Therapeutics SA (NYSE: ADCT) reported that Ameet Mallik, Chief Executive Officer, will participate in a fireside chat at the 2026 Cantor Global Healthcare Conference in New York, NY, on Friday, September 11, 2026, at 9:10 a.m. ET.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live webcast of the presentation will be available via the Events & Presentations page in the Investors section of ADC Therapeutics’ website, ir.adctherapeutics.com. A replay of the webcast will be available for approximately 30 days.

(Press release, ADC Therapeutics, SEP 3, 2026, View Source [SID1234670572])

On September 3, 2026 Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a transformative pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases, reported that management will participate in a fireside chat at the 2026 Annual Cantor Global Healthcare Conference, being held September 9–12, 2026 in New York, NY. Discussion topics will include an overview of the differentiated and favorable tolerability and meaningful clinical activity seen with FT819, the Company’s off-the-shelf CAR T-cell product candidate for the treatment of various autoimmune diseases. The conversation will also focus on the commencement of RECLAIM-LN, the Phase 2 potentially registrational trial in lupus nephritis, as well as the unique safety elements that are incorporated into the design of FT819. Management will also host one-on-one meetings with investors during the conference.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2026 Annual Cantor Global Healthcare Conference

Date: Wednesday, September 9, 2026
Time: 9:45 a.m. EDT
Location: New York, NY
Webcast: Fate Fireside Chat

An archived replay of the webcast will be available for 30 days on the Company’s website following the event under "Events & Presentations" in the Investors section of the Company’s website at www.fatetherapeutics.com.

(Press release, Fate Therapeutics, SEP 3, 2026, View Source [SID1234670571])

On September 3, 2026 Pasithea Therapeutics Corp. (NASDAQ: KTTA) ("Pasithea" or the "Company"), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic oral MEK inhibitor, for the long-term treatment of chronic diseases including the neurocutaneous manifestations of neurofibromatosis type 1 (NF1), reported that management will participate in two investor conferences taking place in September 2026: the 12th Annual Cantor Global Healthcare Conference, hosted by Cantor Fitzgerald, and the H.C. Wainwright 28th Annual Global Investment Conference.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

12th Annual Cantor Global Healthcare Conference

Management will hold one-on-one investor meetings at the 12th Annual Cantor Global Healthcare Conference, taking place September 9-11, 2026, in New York, NY.

H.C. Wainwright 28th Annual Global Investment Conference

Management will also present at the H.C. Wainwright 28th Annual Global Investment Conference, being held September 14-16, 2026, with the Company’s presentation scheduled for Monday, September 14, 2026, at 2:30 PM ET.

(Press release, Pasithea Therapeutics, SEP 3, 2026, View Source [SID1234670570])